LifeMD Total Stockholder Equity vs Total Assets Analysis

LFMD Stock  USD 6.36  0.02  0.32%   
LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Total Stockholder Equity and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Total Stockholder Equity vs Total Assets

Total Stockholder Equity vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Total Stockholder Equity account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between LifeMD's Total Stockholder Equity and Total Assets is 0.48. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Assets in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Total Stockholder Equity and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of LifeMD Inc are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Stockholder Equity i.e., LifeMD's Total Stockholder Equity and Total Assets go up and down completely randomly.

Correlation Coefficient

0.48
Relationship DirectionPositive 
Relationship StrengthWeak

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Total Assets

Total assets refers to the total amount of LifeMD assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in LifeMD Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.
 2021 2022 2023 2024 (projected)
Interest Expense3.0M1.3M2.6M2.7M
Depreciation And Amortization868.8K3.8M6.6M6.9M

LifeMD fundamental ratios Correlations

0.860.960.940.480.76-0.76-0.940.880.960.880.960.890.030.950.840.810.970.950.760.990.490.07-0.220.850.89
0.860.80.840.070.4-0.37-0.820.720.740.890.740.970.130.831.00.720.840.930.40.80.330.180.030.80.95
0.960.80.970.40.84-0.7-0.960.880.880.920.880.860.120.980.760.90.970.950.840.920.680.16-0.430.80.88
0.940.840.970.240.79-0.59-1.00.950.810.960.810.920.00.990.790.941.00.980.790.880.720.04-0.450.870.94
0.480.070.40.240.54-0.92-0.250.290.70.040.70.04-0.080.30.080.070.320.20.540.61-0.07-0.070.020.250.03
0.760.40.840.790.54-0.74-0.810.740.720.680.720.53-0.170.810.340.750.810.681.00.740.77-0.15-0.710.530.58
-0.76-0.37-0.7-0.59-0.92-0.740.6-0.63-0.9-0.39-0.9-0.390.1-0.62-0.37-0.41-0.65-0.54-0.74-0.85-0.210.080.13-0.57-0.38
-0.94-0.82-0.96-1.0-0.25-0.810.6-0.94-0.81-0.96-0.81-0.920.02-0.99-0.77-0.94-1.0-0.97-0.81-0.88-0.74-0.020.47-0.86-0.93
0.880.720.880.950.290.74-0.63-0.940.790.830.790.82-0.050.920.670.890.930.90.740.840.69-0.02-0.410.950.82
0.960.740.880.810.70.72-0.9-0.810.790.71.00.73-0.010.840.730.630.860.830.720.990.30.03-0.080.790.72
0.880.890.920.960.040.68-0.39-0.960.830.70.70.960.070.950.850.930.950.970.680.780.710.11-0.420.770.98
0.960.740.880.810.70.72-0.9-0.810.791.00.70.73-0.010.840.730.630.860.830.720.990.30.03-0.080.790.72
0.890.970.860.920.040.53-0.39-0.920.820.730.960.730.080.910.940.840.920.980.530.810.520.12-0.190.840.99
0.030.130.120.0-0.08-0.170.10.02-0.05-0.010.07-0.010.080.050.150.18-0.010.05-0.170.02-0.011.00.1-0.010.06
0.950.830.980.990.30.81-0.62-0.990.920.840.950.840.910.050.780.940.990.970.810.90.720.09-0.450.840.93
0.841.00.760.790.080.34-0.37-0.770.670.730.850.730.940.150.780.660.790.90.340.790.240.20.120.770.92
0.810.720.90.940.070.75-0.41-0.940.890.630.930.630.840.180.940.660.920.890.750.720.850.2-0.610.780.87
0.970.840.971.00.320.81-0.65-1.00.930.860.950.860.92-0.010.990.790.920.980.810.920.680.02-0.420.870.93
0.950.930.950.980.20.68-0.54-0.970.90.830.970.830.980.050.970.90.890.980.680.890.60.09-0.280.880.98
0.760.40.840.790.541.0-0.74-0.810.740.720.680.720.53-0.170.810.340.750.810.680.740.77-0.15-0.710.530.58
0.990.80.920.880.610.74-0.85-0.880.840.990.780.990.810.020.90.790.720.920.890.740.390.06-0.140.840.8
0.490.330.680.72-0.070.77-0.21-0.740.690.30.710.30.52-0.010.720.240.850.680.60.770.390.0-0.90.460.58
0.070.180.160.04-0.07-0.150.08-0.02-0.020.030.110.030.121.00.090.20.20.020.09-0.150.060.00.10.020.11
-0.220.03-0.43-0.450.02-0.710.130.47-0.41-0.08-0.42-0.08-0.190.1-0.450.12-0.61-0.42-0.28-0.71-0.14-0.90.1-0.12-0.26
0.850.80.80.870.250.53-0.57-0.860.950.790.770.790.84-0.010.840.770.780.870.880.530.840.460.02-0.120.82
0.890.950.880.940.030.58-0.38-0.930.820.720.980.720.990.060.930.920.870.930.980.580.80.580.11-0.260.82
Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.4M13.1M49.9M25.7M58.5M61.4M
Short Long Term Debt Total844.7K1.1M1.8M4.1M18.9M19.9M
Other Current Liab3.1M1.6M10.0M8.9M10.8M11.4M
Total Current Liabilities4.0M13.5M22.8M31.4M34.8M36.5M
Total Stockholder Equity(988.2K)1.4M26.9M(6.8M)3.5M2.1M
Net Debt(261.9K)(8.1M)(39.5M)168.5K(14.2M)(13.5M)
Retained Earnings(16.6M)(80.2M)(141.9M)(190.6M)(214.3M)(203.6M)
Accounts Payable3.1M10.4M9.1M10.1M11.1M11.6M
Cash1.1M9.2M41.3M4.0M33.1M34.8M
Non Current Assets Total699.1K990.3K5.0M14.4M15.9M16.7M
Cash And Short Term Investments1.1M9.2M41.3M4.0M33.1M34.8M
Net Receivables97.4K997.8K980.1K2.8M5.3M5.5M
Common Stock Total Equity534.0K234.3K307.0K315.5K362.9K377.1K
Common Stock Shares Outstanding9.9M14.3M27.0M31.0M33.9M35.6M
Liabilities And Stockholders Equity3.4M13.1M49.9M25.7M58.5M61.4M
Non Current Liabilities Total600.0K385.3K1.3M1.6M18.1M19.0M
Inventory950.1K1.3M1.6M3.7M2.8M2.9M
Other Stockholder Equity15.1M77.6M164.4M178.9M217.4M228.3M
Total Liab4.6M13.9M24.1M33.0M52.9M55.6M
Total Current Assets2.7M12.1M44.9M11.3M42.6M44.7M
Short Term Debt814.7K872.1K1.3M4.3M1.5M903.8K
Common Stock534.0K234.3K307.0K315.5K383.6K380.6K
Other Current Assets443.0K1.8M996.7K814.3K1.9M2.0M
Current Deferred Revenue109.6K916.9K1.5M5.5M8.8M9.3M
Net Tangible Assets(1.7M)(3.0M)19.7M(19.5M)(17.6M)(16.7M)
Net Invested Capital(173.5K)(1.5M)22.8M(8.6M)21.8M22.8M
Short Long Term Debt814.7K779.1K63.4K2.8M327.6K311.2K
Net Working Capital(1.2M)(1.4M)22.1M(20.1M)7.8M8.2M
Capital Stock534.0K3.9M4.4M4.9M383.7K364.5K
Intangible Assets675.5K715.8K3.0M12.7M14.8M15.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
4.847
Quarterly Revenue Growth
0.383
Return On Assets
(0.21)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.